EUVIMEDEUVIMED entdecken
Crossref

HMGB1 ‐Induced Metabolic Rewiring of Macrophages via RAGE / MAPK Fosters Endocrine Resistance in Breast Cancer

Donglin Liu iD, Shengnan Sun, Junning Peng, Shuling Shi, Yuwei Deng iD, Qingyuan Zhang iD

Immunology · 2026

DOI: 10.1111/imm.70182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Donglin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China. Hauptthemen laut MEDLINE: HMGB1 Protein, Breast Neoplasms, Macrophages, Receptor for Advanced Glycation End Products. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Regional Joint Key Project of National Natural Science Foundation of China, General Program of National Natural Science Foundation of China, Key Research and Development Program Project of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endocrine resistance remains a critical challenge in hormone receptor‐positive (HR+) breast cancer. The impact of the immune microenvironment on endocrine therapy efficacy is increasingly recognised, but its mechanisms are not fully understood. Here, we investigated that nuclear HMGB1 expression in tumour cells was closely associated with endocrine therapy resistance in HR+ breast cancer using tumour genomic databases. Specially, tumours with high HMGB1 expression induced M2‐like macrophage polarisation, which was related to HMGB1 paracrine signalling. Mechanistically, HMGB1 bound to the RAGE receptor on macrophages, activating the downstream MAPK signalling pathway and was closely linked to the activation of fatty acid metabolism pathways. Macrophages co‐cultured with high‐HMGB1 tumour cells exhibited metabolic characteristics associated with carcinogenesis, a loss of glycolytic intermediates and a shift toward a pro‐tumourigenic metabolic state compared to those co‐cultured with low‐HMGB1 cells. Co‐culture with M2‐like macrophages significantly activated growth signalling pathways like NF‐κB in the high‐HMGB1 tumour cells. Taken together, high expression of HMGB1 in tumour cells promotes fatty acid metabolic remodelling and functional polarisation in macrophages, contributing to endocrine therapy resistance in HR+ breast cancer. HMGB1 acts as a candidate for immune mediator and paved a way to develop potential target drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinBreast NeoplasmsMacrophagesReceptor for Advanced Glycation End ProductsDrug Resistance, NeoplasmTumor-Associated MacrophagesHumansFemaleMetabolic ReprogrammingCoculture TechniquesTumor MicroenvironmentSignal TransductionFatty AcidsAnimalsCell Line, TumorMAP Kinase Signaling SystemAntineoplastic Agents, Hormonal

Stichwörter der Autor:innen

HMGB1RAGE/MAPK signallingendocrine resistancehormone receptor‐positive breast cancermacrophage polarisationmetabolic remodelling

Substanzen

HMGB1 ProteinReceptor for Advanced Glycation End ProductsHMGB1 protein, humanFatty AcidsAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.

ORCID-Profile: Donglin Liu, Yuwei Deng, Qingyuan Zhang

Förderung

  • Regional Joint Key Project of National Natural Science Foundation of China
  • General Program of National Natural Science Foundation of China
  • Key Research and Development Program Project of Heilongjiang Province

Zitieren

APA

Liu, D., Sun, S., Peng, J., Shi, S., Deng, Y., & Zhang, Q. (2026). HMGB1 ‐Induced Metabolic Rewiring of Macrophages via RAGE / MAPK Fosters Endocrine Resistance in Breast Cancer. Immunology. https://doi.org/10.1111/imm.70182

Vancouver

Liu D, Sun S, Peng J, Shi S, Deng Y, Zhang Q. HMGB1 ‐Induced Metabolic Rewiring of Macrophages via RAGE / MAPK Fosters Endocrine Resistance in Breast Cancer. Immunology. 2026. doi:10.1111/imm.70182

BibTeX
@article{Liu2026,
  author = {Liu, Donglin and Sun, Shengnan and Peng, Junning and Shi, Shuling and Deng, Yuwei and Zhang, Qingyuan},
  title = {HMGB1 ‐Induced Metabolic Rewiring of Macrophages via RAGE / MAPK Fosters Endocrine Resistance in Breast Cancer},
  journal = {Immunology},
  year = {2026},
  doi = {10.1111/imm.70182}
}
Kostenlos starten →